Showing results (51-60 of 141) with videos related to
Sort By:
Pageof 15
Oncology Research|January 1, 1994
Antitumor activity of nigericin and 5-(N-ethyl-N-isopropyl)amiloride: an approach to therapy based on cellular acidification and the inhibition of regulation of intracellular pHK Hasuda, C Lee, I F TannockJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1988
How expert physicians would wish to be treated if they had genitourinary cancerM J Moore, B O'Sullivan, I F TannockBreast Cancer Research and Treatment|August 13, 1999
Third line chemotherapy in patients with metastatic breast cancer: an evaluation of quality of life and costS A McLachlan, M Pintilie, I F TannockCancer|January 15, 1983
Chemotherapy for metastatic transitional carcinoma of the urinary tract. A prospective trial of methotrexate, adriamycin, and cyclophosphamide (MAC) with cis-platinum for failureI F Tannock, M Gospodarowicz, W K EvansBritish Journal of Cancer|July 11, 2002
Cytostatic potential of novel agents that inhibit the regulation of intracellular pHP Wong, H-W Kleemann, I F TannockBritish Journal of Cancer|December 1, 1990
Are treatment strategies of urologic oncologists influenced by the opinions of their colleagues?M J Moore, B O'Sullivan, I F TannockBritish Journal of Cancer|December 1, 1993
Selective cellular acidification and toxicity of weak organic acids in an acidic microenvironmentA R Karuri, E Dobrowsky, I F TannockJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1994
Adjuvant chemotherapy for breast cancer: discordance between physicians' perception of benefit and the results of clinical trialsS Rajagopal, P J Goodman, I F TannockCancer Research|March 1, 1983
Failure of 2-deoxy-D-glucose and 5-thio-D-glucose to kill hypoxic cells of two murine tumorsI F Tannock, P Guttman, A M RauthThe Journal of Urology|October 1, 1993
A phase II study of methotrexate, vinblastine, doxorubicin and cisplatin plus recombinant human granulocyte-macrophage colony stimulating factors in patients with advanced transitional cell carcinomaM J Moore, N Iscoe, I F TannockPageof 15